WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007009147) HOMOGEMCITABINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/009147    International Application No.:    PCT/AT2006/000308
Publication Date: 25.01.2007 International Filing Date: 20.07.2006
IPC:
C07H 19/073 (2006.01), A61K 31/7068 (2006.01)
Applicants: PHARMACON-FORSCHUNG UND BERATUNG GMBH [AT/AT]; Brunnwies 73, A-4780 Brunnenthal (AT) (For All Designated States Except US).
NOE, Christian, R. [AT/AT]; (AT) (For US Only).
JASIC, Muhamed [BA/AT]; (AT) (For US Only).
KOLLMANN, Hermann [AT/AT]; (AT) (For US Only).
SAADAT, Karmin [AT/AT]; (AT) (For US Only)
Inventors: NOE, Christian, R.; (AT).
JASIC, Muhamed; (AT).
KOLLMANN, Hermann; (AT).
SAADAT, Karmin; (AT)
Agent: SONN & PARTNER PATENTANWÄLTE; Riemergasse 14, A-1010 Wien (AT)
Priority Data:
A 1224/2005 20.07.2005 AT
Title (DE) HOMOGEMCITABINE
(EN) HOMOGEMCITABINES
(FR) HOMOGEMCITABINES
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft Homogemcitabine der allgemeinen Formel (2) mit der in Anspruch 1 angegebenen Bedeutungen der Substituenten, Verfahren zu ihrer Herstellung, ihre Verwendung zur Herstellung des Wirkstoffes Gemcitabin und ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung proliferativer Erkrankungen. Weiters betrifft die vorliegende Erfindung neue Zwischenverbindungen, wie sie im erfindungsgemäßen Verfahren Verwendung finden.
(EN)The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1, method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.
(FR)L'invention concerne des homogemcitabines de formule (2), les substituants ayant les significations indiquées à la revendication 1, des procédés pour les réaliser, leur utilisation pour produire la matière active gemcitabine et leur utilisation pour réaliser des médicaments destinés au traitement de maladies prolifératives. La présente invention porte également sur des nouveaux composés intermédiaires tels qu'ils sont utilisés selon le procédé de l'invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)